3/18
11:06 pm
apto
Aptose Biosciences Inc. (NASDAQ: APTO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Neutral
Report
Aptose Biosciences Inc. (NASDAQ: APTO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/18
04:30 pm
apto
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
Neutral
Report
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
2/1
03:30 pm
apto
Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at Piper Sandler from $12.00 to $5.00. They now have an "overweight" rating on the stock.
Low
Report
Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at Piper Sandler from $12.00 to $5.00. They now have an "overweight" rating on the stock.
1/31
10:58 pm
apto
HANMI FILES EARLY WARNING REPORT IN RESPECT OF APTOSE BIOSCIENCES INC. [Yahoo! Finance]
Low
Report
HANMI FILES EARLY WARNING REPORT IN RESPECT OF APTOSE BIOSCIENCES INC. [Yahoo! Finance]
1/31
04:21 pm
apto
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option [Yahoo! Finance]
Low
Report
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option [Yahoo! Finance]
1/31
04:08 pm
apto
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option [Financial Post (Toronto, Ontario, Canada)]
1/31
04:01 pm
apto
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
Low
Report
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
1/29
08:49 am
apto
This Aptose Biosciences Insider Increased Their Holding In The Last Year [Yahoo! Finance]
Low
Report
This Aptose Biosciences Insider Increased Their Holding In The Last Year [Yahoo! Finance]
1/26
09:31 am
apto
Thinking about buying stock in Cipher Mining, SoundHound AI, Cellectar Biosciences, Bitdeer Technologies, or Aptose Biosciences?
High
Report
Thinking about buying stock in Cipher Mining, SoundHound AI, Cellectar Biosciences, Bitdeer Technologies, or Aptose Biosciences?
1/26
09:28 am
apto
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical [Canadian Business Journal (Canada)]
Medium
Report
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical [Canadian Business Journal (Canada)]
1/26
08:10 am
apto
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical [Yahoo! Finance]
High
Report
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical [Yahoo! Finance]
1/26
08:07 am
apto
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical [Financial Post (Toronto, Ontario, Canada)]
1/26
08:00 am
apto
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
High
Report
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical